chr19-51491792-G-A

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_053003.4(SIGLEC12):​c.1637C>T​(p.Pro546Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000382 in 1,597,678 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000039 ( 0 hom., cov: 31)
Exomes 𝑓: 0.000038 ( 0 hom. )

Consequence

SIGLEC12
NM_053003.4 missense

Scores

19

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -0.273

Publications

12 publications found
Variant links:
Genes affected
SIGLEC12 (HGNC:15482): (sialic acid binding Ig like lectin 12) Sialic acid-binding immunoglobulin-like lectins (SIGLECs) are a family of cell surface proteins belonging to the immunoglobulin superfamily. They mediate protein-carbohydrate interactions by selectively binding to different sialic acid moieties present on glycolipids and glycoproteins. This gene encodes a member of the SIGLEC3-like subfamily of SIGLECs. Members of this subfamily are characterized by an extracellular V-set immunoglobulin-like domain followed by two C2-set immunoglobulin-like domains, and the cytoplasmic tyrosine-based motifs ITIM and SLAM-like. The encoded protein, upon tyrosine phosphorylation, has been shown to recruit the Src homology 2 domain-containing protein-tyrosine phosphatases SHP1 and SHP2. It has been suggested that the protein is involved in the negative regulation of macrophage signaling by functioning as an inhibitory receptor. This gene is located in a cluster with other SIGLEC3-like genes on 19q13.4. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2013]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.061962306).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SIGLEC12NM_053003.4 linkc.1637C>T p.Pro546Leu missense_variant Exon 8 of 8 ENST00000291707.8 NP_443729.1 Q96PQ1-1
SIGLEC12NM_033329.2 linkc.1283C>T p.Pro428Leu missense_variant Exon 7 of 7 NP_201586.1 Q96PQ1-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SIGLEC12ENST00000291707.8 linkc.1637C>T p.Pro546Leu missense_variant Exon 8 of 8 1 NM_053003.4 ENSP00000291707.3 Q96PQ1-1
SIGLEC12ENST00000596742.1 linkn.*852C>T non_coding_transcript_exon_variant Exon 8 of 8 1 ENSP00000469791.1 M0QYF3
SIGLEC12ENST00000596742.1 linkn.*852C>T 3_prime_UTR_variant Exon 8 of 8 1 ENSP00000469791.1 M0QYF3
SIGLEC12ENST00000598614.1 linkc.1283C>T p.Pro428Leu missense_variant Exon 7 of 7 5 ENSP00000472873.1 Q96PQ1-2

Frequencies

GnomAD3 genomes
AF:
0.0000395
AC:
6
AN:
151902
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.000121
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000381
AC:
9
AN:
236174
AF XY:
0.0000157
show subpopulations
Gnomad AFR exome
AF:
0.0000624
Gnomad AMR exome
AF:
0.000121
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000280
Gnomad OTH exome
AF:
0.000175
GnomAD4 exome
AF:
0.0000380
AC:
55
AN:
1445776
Hom.:
0
Cov.:
32
AF XY:
0.0000348
AC XY:
25
AN XY:
717892
show subpopulations
African (AFR)
AF:
0.0000303
AC:
1
AN:
33034
American (AMR)
AF:
0.0000694
AC:
3
AN:
43220
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
24870
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39520
South Asian (SAS)
AF:
0.00
AC:
0
AN:
84080
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
51492
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5642
European-Non Finnish (NFE)
AF:
0.0000417
AC:
46
AN:
1104166
Other (OTH)
AF:
0.0000837
AC:
5
AN:
59752
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
4
8
11
15
19
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000395
AC:
6
AN:
151902
Hom.:
0
Cov.:
31
AF XY:
0.0000270
AC XY:
2
AN XY:
74180
show subpopulations
African (AFR)
AF:
0.000121
AC:
5
AN:
41318
American (AMR)
AF:
0.00
AC:
0
AN:
15262
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5170
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4818
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10592
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
67962
Other (OTH)
AF:
0.00
AC:
0
AN:
2084
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.517
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000180
Hom.:
576
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.00
AC:
0
ExAC
AF:
0.0000247
AC:
3

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Jan 02, 2024
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.1637C>T (p.P546L) alteration is located in exon 8 (coding exon 8) of the SIGLEC12 gene. This alteration results from a C to T substitution at nucleotide position 1637, causing the proline (P) at amino acid position 546 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.070
BayesDel_addAF
Benign
-0.45
T
BayesDel_noAF
Benign
-0.66
CADD
Benign
0.50
DANN
Benign
0.31
DEOGEN2
Benign
0.0055
T;.
Eigen
Benign
-1.4
Eigen_PC
Benign
-1.4
FATHMM_MKL
Benign
0.0068
N
LIST_S2
Benign
0.38
T;T
M_CAP
Benign
0.0024
T
MetaRNN
Benign
0.062
T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.8
L;.
PhyloP100
-0.27
PrimateAI
Benign
0.31
T
PROVEAN
Benign
-2.0
N;.
REVEL
Benign
0.011
Sift
Benign
0.21
T;.
Sift4G
Benign
0.32
T;T
Polyphen
0.0060
B;B
Vest4
0.13
MutPred
0.22
Loss of catalytic residue at P545 (P = 0.0138);.;
MVP
0.076
MPC
0.051
ClinPred
0.014
T
GERP RS
-1.2
Varity_R
0.027
gMVP
0.074
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs57043266; hg19: chr19-51995046; API